Aurobindo Pharma Limited has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Olopatadine Hydrochloride Ophthalmic Solution USP, 0.1% which makes the product is ready for launch. 106 more words
Tags » Aurobindo Pharma
Aurobindo Pharma MD and CEO N. Govindarajan at a company research centre. “It is purely driven by the need to get more into areas where there is scope for better profit margins, 1,806 more words
Vice Chairman Of Aurobindo Pharma Foils His Kidnapping | Metro Journalist.
Grudges have been leading to enmity and none can imagine how much worse that enmity can be. 18 more words
FDA INVESTIGATOR FINDS INACCURATE REPORTING OF MICROBIOLOGICAL DATA
The FDA, during August and October 2012 inspected two Apotex, Inc. sites. This Blog only discusses the facilities located at 150 Signet Drive, Toronto, Canada. 505 more words